Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
48.99B | 44.88B | 40.35B | 37.29B | 39.33B | Gross Profit |
48.99B | 44.88B | 40.35B | 37.29B | 39.33B | EBIT |
28.43B | 3.11B | 3.50B | 2.57B | 3.12B | EBITDA |
0.00 | 6.88B | 7.23B | 5.95B | 5.82B | Net Income Common Stockholders |
2.08B | 3.44B | 3.40B | 2.85B | 2.54B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
197.12B | 249.80B | 646.47B | 394.59B | 86.12B | Total Assets |
3.15T | 3.14T | 3.54T | 3.13T | 2.65T | Total Debt |
134.51B | 133.21B | 505.94B | 260.06B | 33.09B | Net Debt |
-197.12B | -116.59B | -140.53B | -134.53B | -53.03B | Total Liabilities |
3.00T | 140.29B | 3.38T | 2.97T | 2.51T | Stockholders Equity |
143.63B | 133.55B | 155.46B | 161.65B | 147.54B |
Cash Flow | Free Cash Flow | |||
-147.49B | -471.44B | 445.89B | 438.09B | 96.80B | Operating Cash Flow |
-158.70B | -469.31B | 450.23B | 440.20B | 100.03B | Investing Cash Flow |
94.19B | 75.43B | -194.68B | -132.94B | -96.69B | Financing Cash Flow |
12.22B | -1.21B | -1.54B | -981.00M | -12.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $862.50B | 12.91 | 5.72% | 3.12% | 9.55% | 9.39% | |
69 Neutral | ¥431.81B | 11.16 | 6.82% | 3.88% | -4.47% | 30.59% | |
66 Neutral | ¥183.41B | 11.75 | 3.39% | 9.37% | 72.56% | ||
65 Neutral | ¥488.38B | 13.35 | 3.41% | 3.63% | 16.68% | 1.73% | |
64 Neutral | $12.61B | 9.78 | 8.01% | 16985.69% | 12.73% | -4.58% | |
52 Neutral | ¥37.57B | 11.55 | 3.68% | -16.07% | 43.79% |